Bayer AG’s BAYRY wholly owned, independently operated subsidiary BlueRock Therapeutics LP announced positive 36-month data ...

Bayer agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses.

Bayer announced today initiation of dosing in a Phase I first-in-human clinical study with 225 Ac-PSMA-Trillium (BAY 3563254), a next-generation targeted alpha therapy. The investigational candidate, ...

In recent days, Bayer’s Consumer Health division announced the selection of Interpublic Group of Companies as its exclusive global creative, production, and media agency partner, consolidating ...

Bayer Advanced aspirin was tested in multiple sites on dental patients who had just had wisdom teeth extracted. The company said 500 mg of the new aspirin started working in 16 minutes and brought ...

American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer are combining in a deal that could help farmers produce higher yields to address challenges from global ...

Bayer announced today initiation of a Phase I clinical trial with 225Ac-GPC3 (BAY 3547926), an investigational targeted alpha radiopharmaceutical being developed to treat tumors expressing Glypican-3 ...

Bournemouth are in advanced negotiations with Bayer Leverkusen to sign Morocco international Amine Adli in a deal worth around £26 million. The 25-year-old, who can operate across the forward line, ...